Assembly Biosciences announces positive interim results from phase 1b study of ABI-5366, a long-acting helicase-primase inhibitor for HSV type 2 with recurrent genital herpes South San Francisco, ...

Understand the three pillars of color—hue, saturation, and value—and how to use them to create striking, harmonious art. A ...

It was the 59th minute when the final pre-season match in Mallorca slipped completely out of Hamburger SV’s hands: Following ...

Sebastian Schonlau is among the losers of the preparation at HSV. Against RCD Mallorca, he even sat on the bench for the full ...

The state viral research and diagnostic laboratory (VRDL) at AIIMS Raipur has received NABL accreditation to diagnose 12 ...

It finally happened. For a while, it looked like HSV are never going back to Bundesliga, a league they have played in every ...

This charming town in Alabama is the perfect place to discover nature trails made from converted railroad tracks as well as small town living. Find out more.

Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.

The 23-year-old had already decided to join Nice and completed a medical with the French club, but the deal collapsed ...

Assembly Biosciences ( NASDAQ: ASMB) reported promising results from an early stage study of its experimental candidate, ...

Favorable safety and tolerability profile observed in the first two cohorts evaluating weekly oral doses of ABI-5366 – SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWS ...